Envoy Medical appoints Robert Potashnick as Chief Accounting Officer and VP of Finance

Envoy Medical, Inc.

Base salary $315,000/yr; initial target bonus of 15% of salary tied to performance milestones.
Initial equity award of 250,000 stock options at $0.746/share (Aug 24, 2026 closing price).
Employment agreement provides 6 months severance for qualifying terminations; 3-year term with auto-renewal.
Potashnick previously served as Interim CFO on contractor basis; prior CFO at FOXO Technologies and Flutterbee Education Group.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.